SPY380.36-1.97 -0.52%
DIA309.45-4.53 -1.44%
IXIC13,192.35+72.96 0.56%

Oxford/Astrazeneca COVID-19 vaccine less effective against S.African variant - FT cites study

· 02/06/2021 15:58
Oxford/Astrazeneca COVID-19 vaccine less effective against S.African variant - FT cites study

- The COVID-19 vaccine developed by AstraZeneca AZN.L and Oxford University does not appear to protect against mild and moderate disease caused by the South African coronavirus variant, the Financial Times reported on Saturday, citing a study due to be published on Monday.



(Reporting by Derek Francis in Bengaluru, Editing by Timothy Heritage)

((derek.francis@thomsonreuters.com; +91-9986311363 and @derekfrancis089 on Twitter;))